Detalles de la búsqueda
1.
Clinical Effectiveness of TetracyclineClass Agents Based Regimens in Patients With Carbapenem-Resistant Acinetobacter baumannii Bacteremia: A Single-Center Retrospective Cohort Study
Journal of Korean Medical Science
; : e263-2023.
Artículo
en Inglés
| WPRIM | ID: wpr-1001087
2.
Clinical Utility of Sero-Immunological Responses Against SARS-CoV-2Nucleocapsid Protein During Subsequent Prevalence of Wild-Type, Delta Variant, and Omicron Variant
Journal of Korean Medical Science
; : e292-2023.
Artículo
en Inglés
| WPRIM | ID: wpr-1001237
3.
Clinical Characteristics and Risk Factors for Mortality in Critical COVID-19 Patients Aged 50 Years or Younger During Omicron Wave in Korea:Comparison With Patients Older Than 50 Years of Age
Journal of Korean Medical Science
; : e217-2023.
Artículo
en Inglés
| WPRIM | ID: wpr-1001105
4.
Loss of Neutralizing Activity of Tixagevimab/Cilgavimab (Evusheld™) Against Omicron BN.1, a Dominant Circulating Strain Following BA.5During the Seventh Domestic Outbreak in Korea in Early 2023
Journal of Korean Medical Science
; : e205-2023.
Artículo
en Inglés
| WPRIM | ID: wpr-1001102
5.
An Outbreak of Breakthrough Infections by the SARS-CoV-2 Delta Variant in a Psychiatric Closed Ward
Journal of Korean Medical Science
; : e28-2022.
Artículo
en Inglés
| WPRIM | ID: wpr-915544
6.
Model-based cost-effectiveness analysis of oral antivirals against SARS-CoV-2 in Korea / 한국역학회지
Epidemiology and Health
; : e2022034-2022.
Artículo
en Ko
| WPRIM | ID: wpr-937554
7.
Severity-Adjusted Dexamethasone Dosing and Tocilizumab Combination for Severe COVID-19
Yonsei Medical Journal
; : 430-439, 2022.
Artículo
en Inglés
| WPRIM | ID: wpr-927170
8.
Risk Factors for Coronavirus Disease 2019 (COVID-19)-Associated Pulmonary Aspergillosis in Critically Ill Patients: A Nationwide, Multicenter, Retrospective Cohort Study
Journal of Korean Medical Science
; : e134-2022.
Artículo
en Inglés
| WPRIM | ID: wpr-925969
9.
Clinical Characteristics and Risk Factors for Mortality in Critical Coronavirus Disease 2019 Patients 50 Years of Age or Younger During the Delta Wave: Comparison With Patients > 50 Years in Korea
Journal of Korean Medical Science
; : e175-2022.
Artículo
en Inglés
| WPRIM | ID: wpr-925912
10.
Predicted and Observed Incidence of Thromboembolic Events among Koreans Vaccinated with ChAdOx1 nCoV-19 Vaccine
Journal of Korean Medical Science
; : e197-2021.
Artículo
en Inglés
| WPRIM | ID: wpr-899916
11.
Predicted and Observed Incidence of Thromboembolic Events among Koreans Vaccinated with ChAdOx1 nCoV-19 Vaccine
Journal of Korean Medical Science
; : e197-2021.
Artículo
en Inglés
| WPRIM | ID: wpr-892212
12.
Adverse Events in Healthcare Workers after the First Dose of ChAdOx1 nCoV-19 or BNT162b2 mRNA COVID-19 Vaccination: a Single Center Experience
Journal of Korean Medical Science
; : e107-2021.
Artículo
en Inglés
| WPRIM | ID: wpr-899840
13.
Adverse Events in Healthcare Workers after the First Dose of ChAdOx1 nCoV-19 or BNT162b2 mRNA COVID-19 Vaccination: a Single Center Experience
Journal of Korean Medical Science
; : e107-2021.
Artículo
en Inglés
| WPRIM | ID: wpr-892136
14.
Ongoing outbreak of human adenovirus-associated acute respiratory illness in the Republic of Korea military, 2013 to 2018
The Korean Journal of Internal Medicine
; : 205-213, 2021.
Artículo
en Inglés
| WPRIM | ID: wpr-875457
15.
Developing a Framework for Pandemic COVID-19 Vaccine Allocation: a Modified Delphi Consensus Study in Korea
Journal of Korean Medical Science
; : e166-2021.
Artículo
en Inglés
| WPRIM | ID: wpr-899941
16.
Developing a Framework for Pandemic COVID-19 Vaccine Allocation: a Modified Delphi Consensus Study in Korea
Journal of Korean Medical Science
; : e166-2021.
Artículo
en Inglés
| WPRIM | ID: wpr-892237
17.
Revised Korean Society of Infectious Diseases/National Evidence-based Healthcarea Collaborating Agency Guidelines on the Treatment of Patients with COVID-19 / 감염과화학요법
Infection and Chemotherapy
; : 166-219, 2021.
Artículo
en Inglés
| WPRIM | ID: wpr-898621
18.
Korean Society of Infectious Diseases/National Evidence-based Healthcare Collaborating Agency Recommendations for Anti-SARSCoV-2 Monoclonal Antibody Treatment of Patients with COVID-19 / 감염과화학요법
Infection and Chemotherapy
; : 395-403, 2021.
Artículo
en Inglés
| WPRIM | ID: wpr-898603
19.
Revised Korean Society of Infectious Diseases/National Evidence-based Healthcarea Collaborating Agency Guidelines on the Treatment of Patients with COVID-19 / 감염과화학요법
Infection and Chemotherapy
; : 166-219, 2021.
Artículo
en Inglés
| WPRIM | ID: wpr-890917
20.
Korean Society of Infectious Diseases/National Evidence-based Healthcare Collaborating Agency Recommendations for Anti-SARSCoV-2 Monoclonal Antibody Treatment of Patients with COVID-19 / 감염과화학요법
Infection and Chemotherapy
; : 395-403, 2021.
Artículo
en Inglés
| WPRIM | ID: wpr-890899